semaglutide and ibd Semaglutide-Associated Ischemic Colitis in a Patient Without Traditional Risk Factors: A Case Report GLP-1 Use in Crohn's Disease:

Both treatments are approved for weight loss and have shown promising results in clinical trials

The best outcomes nearly always come when they are integrated into a larger lifestyle equation: Strength training : Resistance training is vital for preserving and building lean muscle, bone density, and metabolic health, especially while using agents that change weight or body composition like GLP1 or GHrelated peptides

Avoid selfsourcing, untested vials, and multimonth cycles without medical monitoring

[DOI] [PubMed] [Google Scholar] 222.Grammatikopoulou M.G., Gkiouras K., Papageorgiou S., Myrogiannis I., Mykoniatis I., Papamitsou T., Bogdanos D.P., Goulis D.G